CASP3 and lung carcinoma: After three days of treatment, we examined A549 lung cancer cells by flow cytometry to determine their position in the cell cycle and by immunofluorescence using antibodies to the mitotic marker histone H3 and apoptotic marker active caspase-3 to measure mitosis-associated apoptosis.